Science Explorer Back to mapMap
Discussion
Researcher · Research Triangle Park Foundation · United States

Jeffrey M. Besterman

Jeffrey M. Besterman publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors and Cancer therapeutics and mechanisms.

OpenAlex
World rank
#551,381
of 7,710,434 ranked researchers
Rank in United States
#190,541
of 1,627,098
Works
129
Citations
7k
Citations per work
54.3
h-index
48
i10-index 83Top 4.2% in Molecular Biology
Jeffrey M. Besterman

What does Jeffrey M. Besterman research?

Jeffrey M. Besterman's work is mostly in Biochemistry, Genetics and Molecular Biology (59%), Medicine (15%), Chemistry (3%).

Life Sciences: 76 works · 59.0% of their workBiochemistry, Genetics and Molecular Biology: 76 works · 59.0% of their workMolecular Biology: 62 works · 48.3% of their workCancer Research: 9 works · 7.0% of their workCell Biology: 5 works · 3.7% of their workEverything else: 29 works · 22.4% of their workHealth Sciences: 20 works · 15.2% of their workMedicine: 20 works · 15.2% of their workOncology: 15 works · 11.8% of their workHepatology: 4 works · 3.4% of their workPhysical Sciences: 4 works · 3.4% of their workChemistry: 4 works · 3.4% of their workOrganic Chemistry: 4 works · 3.4% of their workTHEIR WORKJeffrey M.Besterman129works
Life Sciences59%Physical Sciences3%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology7659.0%
  2. Everything else2922.4%
    1. Medicine2015.2%
    1. Chemistry43.4%
  1. 1Molecular Biology48% of their works
  2. 2Oncology12% of their works
  3. 3Cancer Research7% of their works
  4. 4Cell Biology4% of their works
  5. 5Hepatology3% of their works
  6. 6Organic Chemistry3% of their works

Research topics

Which keywords describe Jeffrey M. Besterman's research?

The keywords of their largest research topics: Cancer Therapy, HDAC Inhibitors, Histone Deacetylases, Genomic Stability, BET Bromodomains, PROTACs, Tumor Microenvironment and Angiogenesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Cancer Therapy452 topics
  2. HDAC Inhibitors341 topic
  3. Histone Deacetylases341 topic
  4. Genomic Stability282 topics
  5. BET Bromodomains251 topic
  6. PROTACs251 topic
  7. Tumor Microenvironment252 topics
  8. Angiogenesis212 topics
  9. DNA181 topic
  10. Topoisomerases181 topic
  11. DNA Methylation141 topic
  12. HIF-1141 topic
  13. Histone Modification141 topic
  14. Warburg Effect141 topic
  15. Fibroblast Activation Protein111 topic
  16. Immunosuppression111 topic
  17. DNA Structure101 topic
  18. G-Quadruplexes101 topic
  19. Hepatic Stellate Cells101 topic
  20. Liver Regeneration101 topic

Where does Jeffrey M. Besterman work?

Jeffrey M. Besterman's main affiliation in the publication record is Research Triangle Park Foundation, United States.

How many publications and citations does Jeffrey M. Besterman have?

OpenAlex counts 129 works and 7,007 citations for Jeffrey M. Besterman, an h-index of 48, ranking #551,381 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jeffrey M. Besterman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.